Intrinsic Value of S&P & Nasdaq Contact Us

DBV Technologies S.A. DBVT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • FR • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$46.33
+118%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

DBV Technologies S.A. (DBVT) has a negative trailing P/E of -5.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 118.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -18.14%, forward earnings yield 0.85%. PEG 0.76 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.76); analyst target implies upside (+118%).
  • Forward P/E 118.1 — analysts expect a return to profitability with estimated EPS of $0.18 for FY2028.
  • PEG Ratio 0.76 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -18.14% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.85% as earnings recover.
  • Analyst consensus target $46.33 (+118% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 55/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
57/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
21/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — DBVT

Valuation Multiples
P/E (TTM)-5.5
Forward P/E118.1
PEG Ratio0.76
Forward PEG0.76
P/B Ratio4.81
P/S Ratio951.31
EV/EBITDA-4.0
Per Share Data
EPS (TTM)$-0.77
Forward EPS (Est.)$0.18
Book Value / Share$0.88
Revenue / Share$0.00
FCF / Share$-0.64
Yields & Fair Value
Earnings Yield-18.14%
Forward Earnings Yield0.85%
Dividend Yield0.00%
Analyst Target$46.33 (+118%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -6.8 0.13 3.21 108.38 0.00%
2017 -3.4 0.00 3.33 52.83 0.00%
2018 -1.0 0.15 1.12 14.49 -
2019 -2.3 0.07 2.05 26.92 -
2020 -1.8 0.04 1.38 25.14 -
2021 -1.8 0.05 1.78 30.89 -
2022 -2.5 0.08 1.22 49.33 -
2023 -2.5 0.06 1.30 11.55 -
2024 -0.5 -0.01 2.17 0.00 -
2025 -3.6 0.36 3.17 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-4.90 $7.93M $-126.35M -1593.9%
2017 $-42.00 $11.52M $-177.2M -1538.3%
2018 $-39.25 $12.82M $-190.26M -1484.7%
2019 $-26.40 $14.71M $-172.01M -1169.5%
2020 $-18.10 $11.28M $-195.68M -1735.3%
2021 $-8.90 $5.71M $-97.81M -1713.5%
2022 $-6.20 $4.8M $-96.3M -2006.3%
2023 $-3.55 $15.73M $-72.73M -462.4%
2024 $-5.90 $2.57M $-113.92M -4436.1%
2025 $-5.30 $0.00 $-147.4M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.05 $-1.92 – $-0.42 $5.34M $4.38M – $6.7M 4
2027 $-0.34 $-0.45 – $-0.26 $118.44M $97.11M – $148.52M 2
2028 $0.21 $0.16 – $0.27 $447.72M $367.09M – $561.41M 1
2029 $0.67 $0.51 – $0.89 $840.79M $689.37M – $1.05B 1
2030 $1.17 $0.90 – $1.56 $1.23B $1.01B – $1.55B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message